Investor mix
10 investors on record; lead investors include Hatteras Venture Partners, Bios Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 80% |
| Other / undisclosed | 2 | 20% |
Developer protein engineering drugs to treat corneal endothelial diseases
10 investors on record; lead investors include Hatteras Venture Partners, Bios Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 80% |
| Other / undisclosed | 2 | 20% |